
    
      The purpose of this study is to determine whether the combination of stereotatic body
      radiotherapy (SBRT) tand transarterial chemoembolization (TACE) is an effective "bridging
      therapy" for patients hepatocellular carcinoma (HCC) of the liver awaiting transplantation.
    
  